Pds biotech to host interleukin 12 (il-12) immunocytokine-focused kol roundtable on april 21, 2023

Florham park, n.j., april 12, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced it will host a key opinion leader (kol) roundtable on interleukin-12 (il-12) for analysts, investors and the scientific community from 8:00 to 9:00 am, et on april 21, 2023.
PDSB Ratings Summary
PDSB Quant Ranking